Literature DB >> 17913862

Development of a rapid and convenient method for determination of rubella virus-specific immunoglobulin G avidity.

Christelle Vauloup-Fellous1, Jessica Ursulet-Diser, Liliane Grangeot-Keros.   

Abstract

We describe here a rapid and semiautomated method for the determination of rubella virus immunoglobulin G (IgG) avidity with the VIDAS instrument. A total of 153 serum samples from persons with naturally acquired rubella virus infections (n = 98), from vaccinated persons (n = 44), and from patients with autoantibodies (n = 11) were included in this study. The rubella virus-specific IgG avidity assay we developed for the VIDAS instrument was evaluated by comparison with an in-house method. Results obtained with the VIDAS instrument allow considering this method valuable to help confirm or exclude acute primary infection or recent vaccination.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17913862      PMCID： PMC2168184          DOI： 10.1128/CVI.00312-07

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN： 1556-679X


  12 in total

1.  Maturation of rubella IgG avidity over time after acute rubella infection.

Authors:  B Böttiger; I P Jensen
Journal:  Clin Diagn Virol       Date:  1997-08

2.  Humoral immune response after primary rubella virus infection and after vaccination.

Authors:  C Vauloup-Fellous; L Grangeot-Keros
Journal:  Clin Vaccine Immunol       Date:  2007-03-07

3.  Simultaneous IgM reactivity by EIA against more than one virus in measles, parvovirus B19 and rubella infection.

Authors:  H I Thomas; E Barrett; L M Hesketh; A Wynne; P Morgan-Capner
Journal:  J Clin Virol       Date:  1999-10       Impact factor: 3.168

4.  Rubella reinfection and the fetus.

Authors:  L Grangeot-Keros; J C Nicolas; F Bricout; J Pillot
Journal:  N Engl J Med       Date:  1985-12-12       Impact factor: 91.245

5.  Diagnostic value of reverse transcription-PCR of amniotic fluid for prenatal diagnosis of congenital rubella infection in pregnant women with confirmed primary rubella infection.

Authors:  Muriel Macé; Denis Cointe; Caroline Six; Daniel Levy-Bruhl; Isabelle Parent du Châtelet; Didier Ingrand; Liliane Grangeot-Keros
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

6.  Recent rubella virus infection indicated by a low avidity of specific IgG.

Authors:  K Hedman; I Seppälä
Journal:  J Clin Immunol       Date:  1988-05       Impact factor: 8.317

7.  Persistence of specific IgM and low avidity specific IgG1 following primary rubella.

Authors:  H I Thomas; P Morgan-Capner; G Enders; S O'Shea; D Caldicott; J M Best
Journal:  J Virol Methods       Date:  1992-09       Impact factor: 2.014

8.  Rubella-specific serum and nasopharygeal immunoglobulin responses following naturally acquired and vaccine-induced infection. Prolonged persistence of virus-specific IgM.

Authors:  W Al-Nakib; J M Best; J E Banatvala
Journal:  Lancet       Date:  1975-01-25       Impact factor: 79.321

9.  Rubella IgG total antibody avidity and IgG subclass-specific antibody avidity assay and their role in the differentiation between primary rubella and rubella reinfection.

Authors:  G Enders; F Knotek
Journal:  Infection       Date:  1989 Jul-Aug       Impact factor: 3.553

10.  Persistent rubella-specific IgM reactivity in the absence of recent primary rubella and rubella reinfection.

Authors:  H I Thomas; P Morgan-Capner; A Roberts; L Hesketh
Journal:  J Med Virol       Date:  1992-03       Impact factor: 2.327
View more
  1 in total

Review 1.  Diagnosis of Human Immunodeficiency Virus Infection.

Authors:  Bharat S Parekh; Chin-Yih Ou; Peter N Fonjungo; Mireille B Kalou; Erin Rottinghaus; Adrian Puren; Heather Alexander; Mackenzie Hurlston Cox; John N Nkengasong
Journal:  Clin Microbiol Rev       Date:  2018-11-28       Impact factor: 26.132
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.